![Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial - The Lancet Respiratory Medicine Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/1b1f4652-1897-494b-ac3c-f2cd6418a325/gr3.jpg)
Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial - The Lancet Respiratory Medicine
![(PDF) Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation | Emmanuel Tsochatzis and Brian Davidson - Academia.edu (PDF) Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation | Emmanuel Tsochatzis and Brian Davidson - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/50041671/mini_magick20190130-22396-7n29e4.png?1548836585)
(PDF) Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation | Emmanuel Tsochatzis and Brian Davidson - Academia.edu
![REBEL Cast Episode 6: Oseltamivir in the Treatment of Influenza & Use of the HEART Score in Low Risk Chest Pain - REBEL EM - Emergency Medicine Blog REBEL Cast Episode 6: Oseltamivir in the Treatment of Influenza & Use of the HEART Score in Low Risk Chest Pain - REBEL EM - Emergency Medicine Blog](https://rebelem.com/wp-content/uploads/2015/03/REBEL-Cast-Ep6-Tamiflu-and-Heart-Score.png)
REBEL Cast Episode 6: Oseltamivir in the Treatment of Influenza & Use of the HEART Score in Low Risk Chest Pain - REBEL EM - Emergency Medicine Blog
![Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up - Journal of the American Academy of Child & Adolescent Psychiatry Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up - Journal of the American Academy of Child & Adolescent Psychiatry](https://www.jaacap.org/cms/asset/23dc1fbe-9d28-499c-b817-b6cf3e915c1d/fx1.jpg)
Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up - Journal of the American Academy of Child & Adolescent Psychiatry
![Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study - The Lancet Respiratory Medicine Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/a488e04b-3461-490a-9ce2-3a72b0e2b732/gr1.gif)
Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study - The Lancet Respiratory Medicine
![One million haemopoietic stem-cell transplants: a retrospective observational study - The Lancet Haematology One million haemopoietic stem-cell transplants: a retrospective observational study - The Lancet Haematology](https://www.thelancet.com/cms/asset/138896f9-c5ed-45e0-97d5-29ebc964a3ec/gr1.jpg)
One million haemopoietic stem-cell transplants: a retrospective observational study - The Lancet Haematology
![A quantitative textual analysis of the subjective effects of ayahuasca in naïve users with and without depression | Scientific Reports A quantitative textual analysis of the subjective effects of ayahuasca in naïve users with and without depression | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-023-44193-5/MediaObjects/41598_2023_44193_Fig1_HTML.png)
A quantitative textual analysis of the subjective effects of ayahuasca in naïve users with and without depression | Scientific Reports
![Development of spirulina for the manufacture and oral delivery of protein therapeutics | Nature Biotechnology Development of spirulina for the manufacture and oral delivery of protein therapeutics | Nature Biotechnology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41587-022-01249-7/MediaObjects/41587_2022_1249_Fig1_HTML.png)